SCHEMBL2067578

SCHEMBL2067578

CCNC(=O)c1c[c]cnc1NC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 2/20 0.36
CHUK O15111 1/20 0.36
CHIA Q9BZP6 1/20 0.35
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
LMNA P02545 2/20 0.34
TP53 P04637 1/20 0.34
LRRK2 Q5S007 1/20 0.33
CSNK1D P48730 1/20 0.33
CCNE2 O96020 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK2 P24941 1/20 0.33
BRD4 O60885 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HPGDS O60760 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
MAPT P10636 1/20 0.32
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2067342 0.79 CSNK1D (0.36) CHIAHPGDLMNATP53CSNK1D
SCHEMBL27863532 0.73 CHIA (0.53) CHIAHPGDLMNAKMT2AL3MBTL1
SCHEMBL3518480 0.66
SCHEMBL749356 0.66 CNR1 (0.42) LMNAKMT2AL3MBTL1CNR1
SCHEMBL3725252 0.66 GAA (0.39) KMT2AHPGDSTHRBCNR1
SCHEMBL3515969 0.66 IKBKB (0.36) IKBKBCHUKCHIANPC1HPGD
SCHEMBL29066672 0.65 LMNA (0.44) NPC1HPGDLMNABRD4KMT2A
SCHEMBL6625604 0.65 LMNA (0.38) NPC1HPGDLMNABRD4KMT2A
SCHEMBL2066149 0.64
SCHEMBL744918 0.64 HPGDS (0.38) IKBKBCHUKNPC1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES NOVARTIS AG (CH) 2014-01-02 US disclosed
US-8476294-B2 1H-imidazo[4,5-c]quinolinone derivatives NOVARTIS AG (CH) 2013-07-02 US disclosed
EP-2438064-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES Novartis AG (CH) 2012-04-11 EP disclosed
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG 2010-12-16 US disclosed
WO-2010139731-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES NOVARTIS AG (CH) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317657-A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 IKBKB 772/4885CHUK 301/4885CHIA 1086/4885
US-20140005163-A1 1H-IMIDAZO[4,5-C]QUINOLINONE DERIVATIVES PRKCA, CSNK1A1, ABL1 IKBKB 772/4885CHUK 301/4885CHIA 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.